Mumbai-based Kilitch Drugs Ltd plans to enter biosimilars and oral solids, including diabetic and weight-loss tablets, and is ...
With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...
Abbott Laboratories, a global healthcare giant, develops and markets a broad range of medical devices, diagnostics, branded generic medicines, and nutritional products. Its strong focus on innovation ...
Eli Lilly on Thursday launched in India its diabetes and weight-loss drug, Mounjaro, which has already clocked in over $20 ...
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
The ‘miracle’ weight ... market for these drugs is valued at ₹576 crore as of February 2025. It has almost quadrupled in the past five years, expanding at a compound annual growth rate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results